Gofen & Glossberg’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $10K | Hold |
12,740
| – | – | ﹤0.01% | 578 |
|
|
2022
Q3 | $9K | Hold |
12,740
| – | – | ﹤0.01% | 560 |
|
|
2022
Q2 | $8K | Hold |
12,740
| – | – | ﹤0.01% | 565 |
|
|
2022
Q1 | $9K | Hold |
12,740
| – | – | ﹤0.01% | 608 |
|
|
2021
Q4 | $9K | Hold |
12,740
| – | – | ﹤0.01% | 619 |
|
|
2021
Q3 | $16K | Hold |
12,740
| – | – | ﹤0.01% | 610 |
|
|
2021
Q2 | $19K | Hold |
12,740
| – | – | ﹤0.01% | 568 |
|
|
2021
Q1 | $19K | Hold |
12,740
| – | – | ﹤0.01% | 548 |
|
|
2020
Q4 | $19K | Buy |
+12,740
| New | +$19K | ﹤0.01% | 527 |
|